Cencora, Inc. (COR) FCF Payout Ratio: 29.23%
Is Cencora, Inc.’s FCF payout ratio high or low?
Cencora, Inc.'s FCF payout ratio of 29.23% is 91% above its 5-year average of 15.33%, near the high end of its 5-year range (11.55%–29.23%).
112.49% above its 12-month average of 13.76%.
COR FCF Payout Ratio Chart
COR Average FCF Payout Ratio Chart
COR Current vs Average FCF Payout Ratio Chart
COR FCF Payout Ratio Metrics
FCF PAYOUT RATIO
29.23%
FCF PAYOUT RATIO AVG TTM
13.76%
FCF PAYOUT RATIO AVG 3Y
14.20%
FCF PAYOUT RATIO AVG 5Y
15.33%
FCF PAYOUT RATIO AVG 10Y
17.13%
FCF PAYOUT RATIO AVG 15Y
17.06%
FCF PAYOUT RATIO AVG 20Y
14.19%
CURRENT VS TTM AVG
+112.49%
CURRENT VS 3Y AVG
+105.81%
CURRENT VS 5Y AVG
+90.71%
CURRENT VS 10Y AVG
+70.62%
CURRENT VS 15Y AVG
+71.34%
CURRENT VS 20Y AVG
+105.93%
Payout Ratio Comparison
FCF Payout Ratio
29.2%
Earnings Payout Ratio
29.3%
Dividend Yield
0.83%
FCF Yield
2.83%
Annual FCF Payout Ratio History
| Year | Free Cash Flow | Dividends Paid | FCF Payout Ratio |
|---|---|---|---|
| 2025 | $3.21B | $437.08M | 13.6% |
| 2024 | $3.00B | $416.17M | 13.9% |
| 2023 | $3.45B | $398.75M | 11.5% |
| 2022 | $2.21B | $391.69M | 17.7% |
| 2021 | $2.23B | $366.65M | 16.5% |
| 2020 | $1.84B | $343.58M | 18.7% |
| 2019 | $2.03B | $338.97M | 16.7% |
| 2018 | $1.07B | $333.04M | 31.0% |
| 2017 | $1.02B | $320.27M | 31.3% |
| 2016 | $2.71B | $288.48M | 10.6% |
| 2015 | $3.69B | $253.92M | 6.9% |
| 2014 | $1.20B | $214.47M | 17.9% |
| 2013 | $585.67M | $195.72M | 33.4% |
| 2012 | $1.14B | $132.76M | 11.6% |
| 2011 | $999.99M | $117.62M | 11.8% |
| 2010 | $923.99M | $90.62M | 9.8% |
| 2009 | $637.93M | $62.70M | 9.8% |
| 2008 | $599.76M | $48.67M | 8.1% |
| 2007 | $1.09B | $37.25M | 3.4% |
| 2006 | $694.13M | $20.59M | 3.0% |
| 2005 | $1.32B | $10.60M | 0.8% |
| 2004 | $635.80M | $11.20M | 1.8% |
| 2003 | $264.26M | $10.99M | 4.2% |
| 2002 | $471.77M | $10.50M | 2.2% |
| 2001 | ($63.37M) | $0 | N/A (Loss) |
| 2000 | $199.96M | $0 | 0.0% |
| 1999 | ($12.80M) | $0 | N/A (Loss) |
| 1998 | $115.50M | $0 | 0.0% |
| 1997 | ($25.20M) | $0 | N/A (Loss) |
| 1996 | $24.30M | $0 | 0.0% |
Formula: FCF Payout Ratio = Dividends Paid / Free Cash Flow × 100
FCF payout and earnings payout:
- FCF represents operating cash flow after capital expenditures
- FCF payout compares dividends paid with free cash flow
- FCF payout above 100% means dividends paid exceeded free cash flow for the period
- Earnings payout compares dividends paid with net income
Reading the series: Use the chart and table to compare dividend payments with cash generation over time.
Cencora, Inc. FCF Payout Ratio Formula & Definition
FCF Payout Ratio measures what percentage of free cash flow is paid out as dividends. Unlike earnings-based payout, it compares dividends with cash generated after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cencora, Inc. FCF Payout Ratio FAQ
- What is the FCF payout ratio for Cencora, Inc. (COR)?
- The FCF payout ratio for COR stock is 29.23%.
- Is Cencora, Inc.'s FCF payout ratio high or low?
- Cencora, Inc.'s FCF payout ratio of 29.23% is 91% above its 5-year average of 15.33%, near the high end of its 5-year range (11.55%–29.23%).
- What is the TTM average FCF payout ratio for Cencora, Inc. (COR)?
- The TTM average FCF payout ratio for COR stock is 13.76%.
- What is the 3Y average FCF payout ratio for Cencora, Inc. (COR)?
- The 3Y average FCF payout ratio for COR stock is 14.20%.
- What is the 5Y average FCF payout ratio for Cencora, Inc. (COR)?
- The 5Y average FCF payout ratio for COR stock is 15.33%.
- What is the 10Y average FCF payout ratio for Cencora, Inc. (COR)?
- The 10Y average FCF payout ratio for COR stock is 17.13%.
- What is the 15Y average FCF payout ratio for Cencora, Inc. (COR)?
- The 15Y average FCF payout ratio for COR stock is 17.06%.
- What is the 20Y average FCF payout ratio for Cencora, Inc. (COR)?
- The 20Y average FCF payout ratio for COR stock is 14.19%.
Cencora, Inc. FCF Payout Ratio History
| DATE | FCF PAYOUT RATIO |
|---|---|
| 2025-09-30 | 13.63% |
| 2024-09-30 | 13.88% |
| 2023-09-30 | 11.55% |
| 2022-09-30 | 17.75% |
| 2021-09-30 | 16.45% |
| 2020-09-30 | 18.70% |
| 2019-09-30 | 16.67% |
| 2018-09-30 | 30.98% |
| 2017-09-30 | 31.32% |
| 2016-09-30 | 10.63% |
| 2015-09-30 | 6.88% |
| 2014-09-30 | 17.89% |
| 2013-09-30 | 33.42% |
| 2012-09-30 | 11.63% |
| 2011-09-30 | 11.76% |
| 2010-09-30 | 9.81% |
| 2009-09-30 | 9.83% |
| 2008-09-30 | 8.12% |
| 2007-09-30 | 3.42% |
| 2006-09-30 | 2.97% |
| 2005-09-30 | 0.80% |
| 2004-09-30 | 1.76% |
| 2003-09-30 | 4.16% |
| 2002-09-30 | 2.23% |
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch